Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18401,147,1.11 [0.93-1.32],0.234157662084466
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19348,197,1.08 [0.92-1.26],0.3387786462115936
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19122,1393,0.99 [0.93-1.05],0.6985168932673906
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Candidiasis,19362,436,1.05 [0.94-1.16],0.4136053572133082
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18726,3408,1.00 [0.96-1.04],0.9546704742569144
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18709,3465,0.99 [0.96-1.03],0.7516439005477008
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19123,1151,0.99 [0.92-1.06],0.7790235143160775
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19278,105,1.03 [0.83-1.29],0.7600455983594785
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17093,1013,0.97 [0.90-1.04],0.3928646644220296
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16480,1222,0.98 [0.91-1.05],0.5107907817853087
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16125,258,1.03 [0.90-1.19],0.6726066478233153
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12618,2181,0.98 [0.93-1.03],0.4632407216844545
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16082,392,0.96 [0.85-1.09],0.5427180953334534
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19330,1358,1.00 [0.94-1.07],0.9775011196999474
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Mycoses,19429,503,1.05 [0.95-1.15],0.3663455103659372
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18710,981,1.00 [0.92-1.07],0.914212962721118
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19372,1118,0.97 [0.91-1.04],0.4484947602377054
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18169,197,1.07 [0.92-1.25],0.3609791721920585
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19479,49,0.81 [0.56-1.19],0.2915227304256876
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19232,978,0.97 [0.90-1.05],0.4581248796536787
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19234,61,1.20 [0.94-1.54],0.1520114149636163
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19428,108,1.02 [0.82-1.27],0.8800997536502939
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19414,94,0.99 [0.78-1.26],0.952338073186925
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18107,378,1.04 [0.93-1.17],0.5078071319344262
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,17980,251,0.85 [0.72-1.00],0.0569965636039634
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18074,102,1.06 [0.85-1.32],0.5847433391912076
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19464,45,1.12 [0.83-1.52],0.4597155277541687
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19419,151,1.05 [0.88-1.26],0.5852757874053108
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Viral warts,19316,48,1.08 [0.79-1.46],0.6323561505187583
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19340,72,1.07 [0.82-1.38],0.6277028537709826
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign lipomatous neoplasm,19234,218,1.03 [0.88-1.19],0.7454923942359877
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19406,36,0.89 [0.59-1.35],0.5923068266225509
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19392,41,1.32 [1.02-1.72],0.0373005758797811
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9195,71,0.87 [0.65-1.17],0.3635750391412773
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19094,1394,0.99 [0.93-1.05],0.6791182981276929
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm of meninges,19465,55,1.17 [0.90-1.52],0.2460681795893404
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19402,68,0.97 [0.73-1.29],0.8272558927581395
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19456,100,0.92 [0.72-1.17],0.4879052795169694
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm of ovary,10232,65,1.02 [0.77-1.35],0.8942291390120183
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19445,376,0.97 [0.86-1.09],0.5914663337423195
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Caecum,19458,318,0.97 [0.85-1.10],0.632514952522638
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19357,73,1.07 [0.83-1.38],0.6053805529947716
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Descending colon,19444,217,0.84 [0.71-1.01],0.0591674190367024
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Rectum,19402,342,1.06 [0.94-1.19],0.3688263442036837
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19346,579,0.94 [0.85-1.04],0.2516947857338356
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19438,445,0.98 [0.88-1.09],0.7015761203500017
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Carcinoma in situ of breast,7710,44,0.95 [0.67-1.36],0.7921850691652692
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7741,52,0.92 [0.66-1.28],0.6197076650024183
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",13973,61,0.97 [0.72-1.30],0.8176110149125461
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",13993,81,0.85 [0.64-1.14],0.2775473524963371
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19430,109,0.87 [0.68-1.11],0.274498890035444
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Haemangioma, any site",19431,106,0.91 [0.71-1.15],0.4224820528966438
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Leiomyoma of uterus,10002,147,0.92 [0.75-1.12],0.4011934773093547
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Lung cancer and mesothelioma,12433,421,0.97 [0.87-1.09],0.6358505842694833
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Lymphoid leukaemia,13975,63,0.98 [0.73-1.30],0.8699770604841741
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14098,186,0.97 [0.81-1.15],0.6898522354311938
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14169,257,0.87 [0.75-1.02],0.0914592471444308
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",7826,99,1.09 [0.87-1.35],0.4588597714633634
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14003,91,0.96 [0.75-1.23],0.7452547590063077
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14029,117,1.02 [0.83-1.26],0.8295386127749125
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14019,107,0.87 [0.68-1.11],0.2603830257051007
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",7802,75,0.85 [0.63-1.15],0.2896395552055453
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14022,110,1.08 [0.88-1.32],0.4592379986199926
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",6987,802,0.88 [0.80-0.96],0.0036915406233686
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14026,114,1.06 [0.86-1.29],0.5970687277808915
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",13989,77,0.85 [0.64-1.14],0.2809867225509439
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14028,116,1.08 [0.89-1.32],0.4336881677266857
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Melanocytic naevi,19354,159,1.03 [0.86-1.23],0.7592123791154659
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Melanocytic naevi of trunk,19456,67,1.17 [0.92-1.48],0.2038428363545061
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Melanoma in situ,13959,100,1.05 [0.85-1.31],0.6506442769723912
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14013,101,0.90 [0.70-1.15],0.4031013598542858
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14080,168,0.91 [0.75-1.10],0.309945281789088
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14207,295,0.98 [0.86-1.13],0.8230344450948868
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14022,110,0.92 [0.72-1.16],0.4607319258678852
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Other benign neoplasms of skin,19332,144,1.11 [0.93-1.31],0.2509241552472657
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15137,1225,0.94 [0.88-1.01],0.1003987524904391
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15203,1291,0.96 [0.89-1.02],0.1694753692707771
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19224,318,1.04 [0.92-1.18],0.5378739043423914
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,17597,107,0.93 [0.73-1.18],0.5634258448273448
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,18965,59,1.02 [0.76-1.38],0.8782087176695309
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,18878,2863,1.03 [0.99-1.08],0.1116651247526765
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18087,59,1.21 [0.94-1.56],0.1368029179191752
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19092,57,0.90 [0.64-1.25],0.5137927921710246
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19088,1598,1.04 [0.99-1.10],0.1499501029178254
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19086,1596,1.04 [0.99-1.10],0.1520081501484749
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,17585,95,0.91 [0.71-1.17],0.4722338736035786
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19182,1154,1.07 [1.01-1.14],0.0325559891895222
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19137,102,1.16 [0.95-1.41],0.1521456020511485
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,18962,56,0.94 [0.68-1.30],0.7052763041864587
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,18975,69,1.08 [0.84-1.40],0.5312166280240859
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19321,286,0.96 [0.84-1.11],0.5965889277134506
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19373,31,0.83 [0.52-1.32],0.4320366417212178
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19268,233,0.91 [0.77-1.07],0.2311098505548214
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18141,113,0.76 [0.59-0.99],0.0413906883299862
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13170,328,1.03 [0.90-1.16],0.6947474003201314
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18229,87,1.11 [0.89-1.39],0.3697569354391219
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18231,89,1.06 [0.84-1.33],0.6265399831480292
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,12902,60,0.91 [0.66-1.25],0.5705957176618872
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18147,42,0.65 [0.41-1.03],0.068945320518471
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,17534,261,0.87 [0.74-1.02],0.0934209881655089
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",18854,737,0.86 [0.78-0.94],0.0013576561563953
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,18516,399,0.97 [0.87-1.10],0.667156669413674
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18257,140,0.99 [0.82-1.21],0.9448656038253356
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19259,1154,1.07 [1.00-1.14],0.0420121666491475
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,16480,1125,1.07 [1.00-1.14],0.0427469380376052
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",12911,69,0.94 [0.70-1.25],0.6541645320480501
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",17603,87,1.16 [0.93-1.44],0.1885674045936225
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13143,301,0.99 [0.86-1.13],0.8682677839738614
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,12891,49,0.87 [0.60-1.25],0.4400391595728724
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16648,3806,1.01 [0.98-1.05],0.5400473992966193
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13069,227,0.90 [0.76-1.06],0.2153100353431983
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13432,590,0.95 [0.86-1.05],0.2827850830884103
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19433,298,1.06 [0.93-1.20],0.3896171553371856
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19252,117,0.96 [0.76-1.19],0.6881188003007775
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,12965,123,1.11 [0.92-1.35],0.2652322152179971
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",12910,68,0.82 [0.60-1.14],0.2380398245510076
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,18951,1435,1.00 [0.94-1.07],0.9373951378542223
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13140,298,0.88 [0.76-1.02],0.0968503827244488
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13160,318,1.00 [0.87-1.14],0.953124358789
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13553,711,0.99 [0.91-1.08],0.8309958333700218
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,12967,125,0.78 [0.60-1.00],0.0457405510713704
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19247,112,0.96 [0.77-1.21],0.7308584789736021
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,13583,741,1.03 [0.95-1.12],0.4825176685155075
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13372,530,0.95 [0.85-1.05],0.3023328177450822
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17332,59,0.82 [0.58-1.15],0.2512510993339526
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18186,5344,1.00 [0.97-1.03],0.9991625626071456
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,17566,50,1.04 [0.75-1.43],0.8244950360225498
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,17561,45,1.18 [0.87-1.59],0.2901263683324088
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19336,1535,0.95 [0.89-1.01],0.0797627616131269
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19334,1533,0.95 [0.89-1.01],0.0963451684154877
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,17567,51,1.10 [0.81-1.49],0.5378567089768216
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19181,954,1.02 [0.95-1.10],0.5226178676849
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14654,1812,0.98 [0.92-1.03],0.4384971533255917
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19468,242,1.01 [0.87-1.17],0.9070611278427544
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18209,92,0.96 [0.75-1.23],0.7422728998369958
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18327,100,1.15 [0.93-1.41],0.1935361168124366
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18370,143,1.09 [0.91-1.30],0.3537271281965137
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13001,159,1.07 [0.90-1.27],0.4167878898653372
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17153,150,0.85 [0.69-1.05],0.1365039069526203
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2068,81,1.06 [0.84-1.35],0.6063450396322808
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2202,248,1.12 [0.98-1.27],0.0941382759930539
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17070,67,1.04 [0.79-1.36],0.8042733311948742
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2035,49,0.91 [0.63-1.30],0.6043699487302683
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,18799,1796,1.01 [0.95-1.06],0.811940171139925
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,18609,492,0.94 [0.85-1.05],0.2908702561075933
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,17635,362,0.95 [0.83-1.07],0.3975850723562926
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13721,879,1.03 [0.95-1.11],0.5184528314355428
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19366,260,0.90 [0.77-1.05],0.1754891495321163
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18250,227,0.91 [0.77-1.07],0.2612718427332436
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Angina pectoris,16885,1261,0.96 [0.89-1.02],0.1846409285356276
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18337,314,0.90 [0.78-1.03],0.1230368508921174
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18091,68,1.23 [0.98-1.56],0.0791369833168844
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18255,232,0.93 [0.79-1.09],0.3844952662985506
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9947,2320,0.97 [0.93-1.02],0.2811261113234001
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,AV-block,14946,545,1.05 [0.95-1.15],0.358347867249086
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19408,464,0.92 [0.82-1.03],0.144107404873555
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Cardiac arrest,7846,219,1.09 [0.94-1.26],0.2526465110578513
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14572,171,0.97 [0.81-1.16],0.713992333934651
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14490,89,1.07 [0.85-1.35],0.5670176342398299
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19475,59,1.19 [0.92-1.54],0.1840930854840291
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Conduction disorders,15667,1266,1.03 [0.97-1.10],0.3557212926200661
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,17867,2263,0.97 [0.92-1.02],0.1878799313187054
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15777,7475,0.99 [0.96-1.02],0.4035384444223274
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18191,285,0.92 [0.79-1.06],0.2414741556058855
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Endocarditis,14476,75,0.83 [0.61-1.12],0.227365089863318
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19241,1345,1.01 [0.95-1.07],0.7806105702552908
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Hypertension,16804,6611,1.00 [0.97-1.02],0.7879147950122097
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16810,6617,1.00 [0.97-1.02],0.7731222906657251
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19342,83,0.93 [0.71-1.22],0.6037533491143292
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10426,233,1.10 [0.95-1.27],0.1969519576240693
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10311,118,1.04 [0.84-1.28],0.7286238007259258
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Hypotension,19330,1287,1.05 [0.99-1.12],0.0968030985009055
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18434,119,0.83 [0.65-1.05],0.1237590769724143
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18014,2390,0.98 [0.93-1.02],0.3274898850498946
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19071,651,0.98 [0.89-1.07],0.6058169899615128
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Left bundle-branch block,14823,422,1.06 [0.95-1.18],0.2894181111075939
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,18926,879,1.00 [0.93-1.08],0.9219506329389962
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16380,756,1.04 [0.96-1.13],0.3045200499797351
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19368,158,1.19 [1.02-1.39],0.025518775283117
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19441,343,1.05 [0.93-1.18],0.4611447801132953
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Oesophageal varices,17964,58,0.75 [0.52-1.08],0.122368757938888
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other aneurysm,18105,82,1.01 [0.79-1.30],0.9142416728755212
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other arrhythmias,14887,486,0.96 [0.86-1.07],0.4750338602837369
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18132,109,1.05 [0.85-1.30],0.6612555630999617
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18293,270,1.03 [0.90-1.18],0.6913843318599754
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14586,185,1.01 [0.85-1.20],0.9197094855740064
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other disorders of veins,17992,86,0.97 [0.75-1.25],0.8151692684625578
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,17943,37,0.92 [0.62-1.37],0.6846694224097409
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,17811,73,0.98 [0.74-1.28],0.8675265714274498
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18044,138,1.00 [0.82-1.22],0.998319326051858
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15572,1171,0.97 [0.90-1.04],0.3765583186580342
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18093,50,1.12 [0.83-1.51],0.4532528485175168
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18617,594,1.03 [0.94-1.13],0.5173918676305367
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,18832,448,1.06 [0.96-1.18],0.2540238182066385
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",18526,788,1.01 [0.93-1.10],0.7735148224957684
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,7974,347,0.93 [0.82-1.06],0.2965727741562232
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18471,477,1.02 [0.92-1.13],0.7435455020214297
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18260,354,0.94 [0.82-1.06],0.3172309087575484
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Pulmonary embolism,18881,497,1.01 [0.91-1.12],0.901170972495144
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19393,785,0.99 [0.91-1.08],0.8735330211037097
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Right bundle-branch block,14830,429,1.03 [0.92-1.15],0.593176458608566
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Secondary right heart disease,18828,444,1.07 [0.96-1.19],0.2081997232655345
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,17950,212,1.08 [0.93-1.25],0.3293627820489242
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19055,740,0.96 [0.88-1.05],0.4069128621494726
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19044,773,0.97 [0.89-1.05],0.4350922101813097
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18411,50,1.01 [0.73-1.39],0.958861721543239
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18106,83,0.87 [0.66-1.14],0.3161976343312592
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18676,256,1.07 [0.94-1.23],0.3017026016135646
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18321,274,0.90 [0.78-1.05],0.1891097755265589
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Varicose veins,18323,417,1.08 [0.97-1.20],0.1635653305559113
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18039,98,0.77 [0.58-1.02],0.067274448128203
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19242,783,0.97 [0.89-1.05],0.4275983710387588
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19412,278,1.15 [1.02-1.30],0.0215275068507563
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16750,1165,1.04 [0.98-1.11],0.1885420888815254
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,Any mental disorder,19052,3467,1.04 [1.00-1.08],0.0404142606804638
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19387,327,1.13 [1.01-1.26],0.0407219208856649
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16759,1174,1.06 [1.00-1.13],0.0625999403555429
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15649,64,0.82 [0.59-1.14],0.2320340840364312
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,Smoking dependency,19059,974,1.02 [0.95-1.10],0.6214809068833114
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16789,1204,1.04 [0.97-1.11],0.2493297437495996
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,Vascular dementia,18784,192,0.91 [0.76-1.09],0.3245354336229931
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Alzheimer disease,19476,492,0.98 [0.88-1.09],0.7659843336274654
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",12148,92,0.97 [0.75-1.24],0.7952416895934866
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Bell's palsy,17959,71,0.88 [0.65-1.19],0.4037385440082492
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18297,409,0.95 [0.84-1.07],0.3953829531866448
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Cerebral cysts,19116,204,1.05 [0.90-1.22],0.5510001224457033
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19415,317,0.92 [0.80-1.06],0.2603385029114633
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,18795,69,1.08 [0.83-1.39],0.5753578831993431
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19460,60,1.03 [0.77-1.38],0.8346521012089254
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",18981,69,0.96 [0.72-1.28],0.7794176847393107
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Epilepsy,18258,242,0.98 [0.85-1.14],0.8044447423956641
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19105,1089,1.02 [0.95-1.09],0.5469522149895056
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19428,525,0.99 [0.89-1.09],0.8325893020558294
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Falls/tendency to fall,18931,2785,0.99 [0.95-1.04],0.7401311708368387
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Generalized epilepsy,19180,44,1.27 [0.98-1.66],0.0714226431315224
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Hemiplegia,19358,260,1.00 [0.86-1.15],0.9819881081434166
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Hydrocephalus,18972,60,0.93 [0.68-1.27],0.6560589468905693
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19464,57,1.11 [0.85-1.47],0.4448217896295325
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,17950,62,1.18 [0.92-1.51],0.1835150696093206
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,17952,64,0.96 [0.71-1.29],0.768269866815522
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Memory loss,18575,129,1.04 [0.86-1.27],0.6686237537656807
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Migraine,18249,233,0.95 [0.82-1.11],0.5478892566101529
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19436,212,0.93 [0.79-1.10],0.3988449718838694
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Motor neuron disease,12235,158,0.93 [0.77-1.13],0.4841594584671926
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19371,48,1.01 [0.73-1.39],0.9534449631796456
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",18894,1006,0.97 [0.90-1.05],0.4540825592743853
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Neurological diseases,18254,3439,0.99 [0.95-1.03],0.5656985940751077
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,18964,238,0.99 [0.85-1.15],0.8516051607262212
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18218,330,0.95 [0.84-1.09],0.4854555431931127
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19414,280,1.12 [0.99-1.27],0.0809836819059029
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14791,786,0.99 [0.91-1.07],0.7295914135560024
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,18980,68,1.14 [0.89-1.46],0.3026391487911902
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19041,129,0.87 [0.69-1.09],0.2121213204371633
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19080,177,1.04 [0.88-1.23],0.6570276544833442
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other facial nerve disorders,17966,78,0.87 [0.66-1.16],0.3530015288089981
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other headache syndromes,18062,46,0.77 [0.51-1.15],0.2032330314712132
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other neurological diseases,19384,472,1.03 [0.93-1.15],0.5307384254265294
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other sleep disorders,18427,411,0.99 [0.88-1.11],0.8135713981721944
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Parkinson's disease,19446,330,0.93 [0.82-1.07],0.3157741121298372
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,18950,38,1.15 [0.84-1.58],0.3875616103058925
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Restless leg syndrome,19475,77,0.87 [0.65-1.16],0.3442904918518055
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Sleep apnoea,19293,354,0.97 [0.86-1.10],0.6909865741906319
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19182,48,1.19 [0.90-1.57],0.22358084298407
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19464,178,0.90 [0.75-1.08],0.2521817745664931
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,17946,58,1.19 [0.93-1.53],0.17612529210952
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19476,497,0.99 [0.89-1.10],0.8404586777512693
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),18730,186,0.91 [0.76-1.10],0.3341815456919472
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,18946,126,1.06 [0.88-1.29],0.5355403310452693
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19114,478,0.92 [0.83-1.03],0.167368881274162
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19273,219,0.99 [0.85-1.16],0.9347570283928598
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,18445,52,1.05 [0.78-1.43],0.7424972496689806
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18426,33,1.29 [0.94-1.75],0.1103398659677906
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19374,61,0.94 [0.69-1.29],0.7105816878671959
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19213,192,0.77 [0.63-0.94],0.0098509573037474
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2039,52,0.95 [0.68-1.33],0.7518852676345942
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2513,92,1.07 [0.85-1.34],0.5575193075207588
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,18909,89,1.12 [0.90-1.39],0.3261445975420459
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19242,1181,1.04 [0.97-1.11],0.2757442359393328
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19124,731,1.07 [0.99-1.16],0.1020203925834984
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18646,253,1.19 [1.05-1.34],0.0063618343187342
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19421,785,0.97 [0.90-1.06],0.5217764937637857
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19470,66,1.10 [0.85-1.42],0.4547973576928251
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19372,736,0.96 [0.88-1.05],0.3840427985133025
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19444,423,0.96 [0.85-1.08],0.4741241617138052
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19377,188,0.84 [0.70-1.02],0.0787211444599032
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,18480,87,1.11 [0.89-1.39],0.3524340990360276
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,18479,86,0.78 [0.58-1.05],0.1046515006376488
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,18458,65,1.29 [1.03-1.61],0.0271273660231987
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19365,849,0.98 [0.91-1.06],0.6283590719418999
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,18751,235,0.92 [0.79-1.08],0.3289060052992059
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,18690,54,1.20 [0.93-1.57],0.166329533886422
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19125,104,0.99 [0.79-1.24],0.9230935025934758
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19351,330,0.93 [0.82-1.07],0.3035434912568845
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,18820,184,1.03 [0.87-1.21],0.7481686064601176
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19306,117,0.70 [0.54-0.92],0.0092741283953598
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19068,552,1.01 [0.91-1.11],0.9072419491510696
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,18952,132,1.07 [0.88-1.29],0.5053085607768963
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17450,2715,1.00 [0.95-1.04],0.9457336419757482
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19315,294,0.92 [0.80-1.06],0.2503624218054707
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19461,159,1.02 [0.85-1.22],0.8539047837269327
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,18844,451,1.04 [0.93-1.15],0.5042820545320771
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19097,76,0.89 [0.66-1.19],0.4212437554943087
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19463,59,1.10 [0.84-1.45],0.4759185681276769
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,18499,106,0.94 [0.75-1.19],0.634092520235602
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18545,152,1.08 [0.91-1.28],0.3967455366052373
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18195,134,1.25 [1.06-1.46],0.0069032537777727
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,18679,43,0.89 [0.61-1.30],0.5451819949149899
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18122,61,0.93 [0.68-1.26],0.6348920384960195
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,18613,97,0.82 [0.63-1.07],0.1466544018404664
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",18759,243,0.99 [0.85-1.15],0.8765211502571799
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,18517,124,1.00 [0.82-1.23],0.9677037583761368
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18138,77,1.25 [1.02-1.53],0.0337161084386216
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18165,104,1.17 [0.96-1.42],0.1128562830964377
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,16987,2252,1.00 [0.95-1.05],0.9028322202952056
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,18472,79,1.20 [0.97-1.49],0.0993025069682203
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19235,415,1.03 [0.92-1.15],0.6460546657416545
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,18884,64,0.88 [0.64-1.21],0.4290939467409213
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),18980,160,1.03 [0.86-1.23],0.7596578754054861
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19280,91,0.88 [0.67-1.14],0.325913500565731
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19440,120,0.94 [0.75-1.16],0.5524537456699244
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19368,95,1.01 [0.80-1.27],0.9507218479490988
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19246,57,0.94 [0.68-1.29],0.694331892614531
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,19249,60,0.86 [0.62-1.20],0.3755994107809974
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19383,984,1.00 [0.93-1.08],0.9765528311528532
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19147,748,1.01 [0.93-1.10],0.7268439830598025
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,18523,124,1.11 [0.92-1.34],0.2721357774611864
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,18471,72,1.11 [0.87-1.42],0.4064580835422176
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Acute pharyngitis,19310,52,0.70 [0.47-1.04],0.0772465775547132
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19408,150,0.70 [0.56-0.89],0.0032230736116372
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19308,50,0.75 [0.51-1.11],0.1530327103184228
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,All influenza,17314,122,1.03 [0.84-1.26],0.7729863024682659
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17311,119,1.03 [0.84-1.26],0.7863310813039779
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12093,81,1.29 [1.08-1.56],0.0063521011578089
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Allergic rhinitis,19392,198,0.98 [0.83-1.15],0.8035264895496212
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13161,1462,0.99 [0.93-1.05],0.6268845848688289
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13458,1446,0.98 [0.92-1.04],0.5656066105982499
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19049,149,1.00 [0.83-1.21],0.9954751603982264
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17275,83,1.03 [0.80-1.31],0.8378981593058306
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Bronchiectasis,16308,428,1.05 [0.94-1.17],0.3670958409448184
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",15939,59,1.19 [0.93-1.51],0.1690800902757087
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18537,2657,1.00 [0.95-1.04],0.8429064903255173
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18448,66,0.80 [0.57-1.11],0.1765100909468908
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Chronic sinusitis,18493,111,0.91 [0.72-1.15],0.4367756466384553
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19234,1351,0.95 [0.89-1.02],0.143921018679055
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Deviated nasal septum,18451,69,0.88 [0.65-1.19],0.4231319022431296
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17673,5065,1.00 [0.97-1.03],0.9423229918367944
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18670,288,0.85 [0.73-0.99],0.0360759290373719
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Early onset COPD,17980,97,1.02 [0.82-1.28],0.832793339120007
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Emphysema,16247,367,1.01 [0.89-1.14],0.8922101018783932
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18361,392,1.05 [0.94-1.17],0.4134808386404717
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19255,2063,0.98 [0.93-1.03],0.4334139346726386
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Interstitial lung disease,18395,426,1.06 [0.96-1.18],0.2623263549058557
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Later onset COPD,19030,1254,0.95 [0.88-1.01],0.1135487983167413
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19461,372,1.03 [0.92-1.16],0.566942550609625
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Nasal polyp,18466,84,1.04 [0.82-1.33],0.7201496539567227
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19237,1041,1.01 [0.95-1.09],0.6848242421068043
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other diseases of pleura,19236,2214,1.01 [0.97-1.07],0.5549222658936993
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19016,634,0.91 [0.82-1.00],0.0517252725423188
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other pleural conditions,17072,50,0.81 [0.56-1.18],0.276749186915141
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19360,504,1.07 [0.97-1.18],0.1716645648219678
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19365,1416,1.01 [0.95-1.08],0.6692875275852791
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pleural effusion,18122,1100,1.01 [0.94-1.08],0.816228231660024
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pleural plaque,17238,216,1.08 [0.93-1.25],0.3283759304354461
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19020,1828,0.98 [0.93-1.03],0.4232566421493702
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19367,278,1.00 [0.87-1.14],0.964565943679103
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pneumothorax,17172,150,0.84 [0.68-1.04],0.1146347322281533
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pollen allergy,19467,166,0.98 [0.82-1.17],0.8403858973306746
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pulmonary oedema,18932,76,0.95 [0.71-1.25],0.6929310509982791
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12069,57,1.29 [1.01-1.64],0.0377390127984143
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19223,1027,1.02 [0.95-1.09],0.6642223731389418
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18581,199,0.98 [0.83-1.15],0.7890092928008544
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Viral pneumonia,17435,243,0.90 [0.77-1.05],0.1902695159053538
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19061,195,0.83 [0.69-1.01],0.057428668727486
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6296,97,0.87 [0.67-1.13],0.3004073211749469
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12455,53,1.11 [0.83-1.47],0.4880865329463129
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Acute appendicitis,19375,109,1.15 [0.95-1.40],0.1401444031912902
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Acute gastritis,13619,82,0.91 [0.69-1.20],0.4938566531237583
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Acute pancreatitis,17788,164,0.99 [0.82-1.18],0.8780075618187424
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Acute peritonitis,19080,92,1.02 [0.81-1.29],0.8792318184386523
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Alcoholic liver disease,18648,48,0.73 [0.48-1.11],0.1384426444623318
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Barrett oesophagus,13954,417,0.92 [0.82-1.04],0.1964861339097816
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",17745,121,1.27 [1.08-1.50],0.0036902304169817
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19132,121,1.28 [1.09-1.51],0.0030909595912547
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Cholecystitis,17800,176,0.96 [0.81-1.15],0.6932045497073208
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Cholelithiasis,18499,875,1.00 [0.93-1.08],0.9976883702941922
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Chronic gastritis,13823,286,1.00 [0.87-1.15],0.9910472603459984
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Chronic pancreatitis,17668,44,0.67 [0.43-1.04],0.077063439187225
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19365,106,0.99 [0.79-1.25],0.9547511943154776
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Coeliac disease,18034,103,1.30 [1.10-1.54],0.0018266669246522
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Collagenous colitis,18012,88,0.67 [0.49-0.92],0.0133833339822092
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19377,140,1.00 [0.82-1.21],0.981660531224956
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Constipation,19241,1719,0.96 [0.90-1.01],0.1386121962798968
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Crohn disease,17991,67,1.14 [0.89-1.46],0.3079713875017251
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19184,52,1.09 [0.81-1.47],0.559344165655502
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Crohn's disease NAS,17985,61,1.18 [0.92-1.52],0.1904662630035237
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Dental caries,18954,159,1.05 [0.88-1.25],0.586670251081581
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16880,2138,1.00 [0.95-1.05],0.896205688420759
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of appendix,19401,135,1.10 [0.92-1.32],0.2753531008442628
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of liver,19381,781,1.01 [0.93-1.10],0.8046209716940158
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17361,3824,1.00 [0.97-1.04],0.8343298117865383
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19193,398,0.99 [0.88-1.11],0.8019520451603652
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19402,414,0.94 [0.84-1.06],0.3393896316305261
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,18872,77,0.82 [0.61-1.11],0.1989036009304185
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of salivary glands,18768,46,0.99 [0.71-1.39],0.9539716063692284
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19205,1274,1.01 [0.95-1.08],0.6722083773351902
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of tongue,18779,77,0.95 [0.72-1.24],0.6939275016772034
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18891,1267,0.99 [0.93-1.06],0.7552856821590659
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15579,3177,0.97 [0.93-1.01],0.112240065871797
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Duodenal ulcer,13736,199,0.91 [0.77-1.09],0.3142434683943699
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19393,160,0.92 [0.76-1.12],0.3943043130546407
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19448,19,1.03 [0.63-1.69],0.9067111975216324
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,18724,124,0.98 [0.79-1.21],0.8227590975856947
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12496,94,1.06 [0.85-1.33],0.605900026091138
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Functional dyspepsia,14013,476,1.00 [0.90-1.11],0.9637368249223776
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Gastric ulcer,13894,357,1.04 [0.92-1.17],0.5274441940037147
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15754,2217,0.96 [0.92-1.01],0.1583359913819017
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14073,536,0.99 [0.89-1.09],0.7806581167511958
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14141,6909,1.00 [0.97-1.03],0.98754771316059
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,GI-bleeding,18978,1047,1.00 [0.93-1.07],0.9248934542617728
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,18839,44,0.83 [0.56-1.22],0.3406516775177601
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13223,981,0.91 [0.85-0.99],0.0251834258385641
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",18656,56,0.97 [0.71-1.33],0.8553939349547293
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Hernia,17771,3029,0.98 [0.94-1.02],0.3461540911651396
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Impacted teeth,19450,18,1.08 [0.66-1.75],0.7609597925147915
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Impaction of intestines,12464,62,1.04 [0.79-1.38],0.7636469160798356
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Inguinal hernia,15659,917,0.94 [0.87-1.01],0.1125859910461046
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",14839,97,0.83 [0.64-1.08],0.1676076132245403
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12501,99,0.79 [0.60-1.03],0.0866740194192015
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18053,122,1.19 [1.01-1.41],0.0431097127853855
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12830,428,0.98 [0.88-1.10],0.7210283233724162
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19453,277,1.11 [0.97-1.26],0.1222353493946126
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18583,659,1.05 [0.97-1.15],0.2462205893938568
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,18839,915,1.01 [0.94-1.09],0.8117963361737373
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13719,182,0.86 [0.71-1.04],0.1204571595961001
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Oesophagitis,14126,589,0.98 [0.89-1.08],0.7402536101052514
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19428,113,0.92 [0.73-1.15],0.4568637233086551
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,14812,70,0.99 [0.75-1.31],0.961636878943686
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13560,1158,1.01 [0.94-1.08],0.8210431557980016
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,17921,297,1.01 [0.89-1.16],0.8409608917342941
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,17745,121,1.09 [0.90-1.32],0.3768208695686943
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of intestine,14009,1607,1.00 [0.95-1.06],0.9399720095276854
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of intestines,17545,5143,0.99 [0.96-1.02],0.4389273441782547
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18752,181,0.92 [0.77-1.10],0.3624106305449028
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of liver,19246,646,0.99 [0.90-1.08],0.7964506070110464
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14177,640,0.98 [0.90-1.08],0.7050073736614504
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of pancreas,17800,176,0.94 [0.78-1.12],0.472833338859051
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19337,349,0.93 [0.81-1.05],0.245269774200961
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14461,924,0.97 [0.90-1.05],0.4534978360035256
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,18990,1059,0.99 [0.93-1.07],0.8565767956308237
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,18944,149,1.06 [0.89-1.27],0.4944568380658435
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14158,1756,0.95 [0.90-1.01],0.0928849603330301
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15339,1802,0.98 [0.93-1.04],0.5699186076502222
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,18696,96,1.10 [0.88-1.36],0.4000532241165858
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18737,813,0.99 [0.91-1.07],0.726742911379952
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12767,365,0.96 [0.84-1.08],0.4836712622421912
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19445,23,1.09 [0.71-1.66],0.7020326404405447
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,12914,512,0.96 [0.86-1.07],0.4422309192937002
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18068,137,0.96 [0.79-1.18],0.7157916601418929
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19464,43,0.82 [0.55-1.23],0.3390108459327162
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,18789,83,1.02 [0.80-1.30],0.8613564855155977
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Toxic colitis,17993,69,0.81 [0.59-1.12],0.209583043206214
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,13830,293,0.97 [0.85-1.12],0.7000699788218128
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Ulcerative colitis,18058,134,1.13 [0.94-1.34],0.1834643374083559
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18031,107,1.06 [0.86-1.31],0.5566999706529665
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Umbilical hernia,14949,207,1.04 [0.90-1.22],0.5758793627226817
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12603,201,0.95 [0.80-1.12],0.5398104135736371
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Ventral hernia,14968,226,0.96 [0.82-1.12],0.6033374780392214
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Volvulus,12477,75,1.11 [0.87-1.41],0.4057671459738982
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19388,340,1.06 [0.94-1.19],0.3184218695738176
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19174,61,0.79 [0.56-1.12],0.1815905360468412
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17389,142,0.91 [0.75-1.12],0.3892599167162691
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,18960,686,0.97 [0.89-1.07],0.5721366143636823
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18391,117,0.93 [0.74-1.16],0.5053753918995609
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,17730,483,0.91 [0.82-1.02],0.12041056995254
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19186,259,0.96 [0.83-1.12],0.6149071950088035
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19385,458,1.01 [0.91-1.13],0.8153288931984104
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,18970,43,1.26 [0.96-1.67],0.0962104762889531
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18127,3082,0.96 [0.92-1.00],0.0455697540363466
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19109,369,0.92 [0.81-1.04],0.1764870807526418
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,18997,257,0.93 [0.80-1.08],0.3501690291068802
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19158,884,0.95 [0.88-1.03],0.2546373229677297
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19459,51,1.20 [0.91-1.57],0.1878351218760807
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17302,55,0.89 [0.64-1.25],0.5135709738855762
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,18793,53,0.79 [0.54-1.14],0.2120194198483752
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19174,247,0.97 [0.83-1.12],0.6464022923382635
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17748,501,0.97 [0.87-1.08],0.5669407534337025
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17326,79,0.74 [0.54-1.02],0.0640924449627105
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19407,72,0.86 [0.63-1.16],0.323224701160221
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18448,174,1.00 [0.84-1.20],0.9573797825037534
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19300,187,0.85 [0.70-1.03],0.0925061047664341
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,18999,72,0.94 [0.70-1.25],0.657833746366135
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17307,60,0.92 [0.67-1.26],0.6116182674600259
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,18960,1713,0.97 [0.91-1.02],0.2324295263055158
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17786,539,0.98 [0.89-1.08],0.6843150155444195
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17328,81,0.75 [0.55-1.01],0.061928244977821
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19398,285,0.91 [0.79-1.06],0.2288041990263274
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,18992,65,1.05 [0.80-1.37],0.7518989673944162
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19346,233,0.87 [0.73-1.02],0.0919316754020719
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19416,368,1.04 [0.93-1.16],0.5183045867179044
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17354,107,0.91 [0.72-1.15],0.4414520578436873
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17521,274,0.95 [0.83-1.10],0.503809722217964
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19405,357,1.04 [0.93-1.17],0.4803628697584038
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",17505,258,1.12 [0.98-1.27],0.0984170375842289
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19454,119,0.93 [0.75-1.17],0.5464070426603668
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16245,66,1.00 [0.75-1.33],0.9944653660241456
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17184,5378,0.99 [0.96-1.02],0.6244491478518036
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16004,4198,0.99 [0.96-1.03],0.5897989621686408
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16224,45,1.04 [0.75-1.44],0.8214035076126153
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16229,118,1.01 [0.82-1.24],0.9297743383526644
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16268,157,0.90 [0.73-1.09],0.2729088936935057
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19256,50,0.76 [0.51-1.12],0.1638906265702023
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16235,124,0.87 [0.69-1.09],0.2157050740099673
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13057,1251,0.98 [0.92-1.04],0.5155807413976552
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19290,209,1.08 [0.93-1.25],0.3138432732745008
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16574,463,0.94 [0.84-1.05],0.3036479142435042
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15786,6725,1.00 [0.97-1.03],0.998363353815718
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17398,102,0.80 [0.61-1.05],0.1043522138761443
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16326,147,0.95 [0.78-1.16],0.619868048485964
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16610,431,1.06 [0.95-1.17],0.3135413721995783
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18690,2579,0.97 [0.93-1.02],0.2560047076797008
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16446,267,0.94 [0.81-1.08],0.3744466209945823
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16300,121,1.14 [0.95-1.37],0.1521764501884068
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16278,99,1.01 [0.80-1.26],0.9567816219830694
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,18823,87,0.98 [0.76-1.26],0.882947030904567
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13485,1679,1.01 [0.96-1.07],0.6065950875898479
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12438,632,1.02 [0.93-1.11],0.7461836603078479
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19398,626,1.03 [0.94-1.12],0.586649606439736
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,11865,59,0.93 [0.69-1.27],0.6549881488339417
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12066,260,1.01 [0.88-1.15],0.9252093584089888
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16403,224,1.06 [0.92-1.23],0.3934422344853674
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12216,410,1.08 [0.98-1.20],0.1370807491572515
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16174,63,1.06 [0.81-1.40],0.6598767128845864
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16671,560,0.95 [0.86-1.05],0.298782034027259
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16364,253,0.98 [0.85-1.13],0.7680346186331638
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12190,384,1.10 [0.99-1.22],0.0865942145397549
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16237,58,0.84 [0.59-1.18],0.3077778758510057
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16227,48,1.16 [0.86-1.55],0.327066596090286
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17361,65,1.11 [0.85-1.44],0.4459170429158106
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19122,1826,0.99 [0.94-1.04],0.6807860782355515
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,18584,1288,1.00 [0.93-1.06],0.922347717963232
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19335,452,0.97 [0.87-1.09],0.6330326545369496
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14406,2600,0.98 [0.93-1.02],0.33987274494299
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,11845,39,1.07 [0.77-1.50],0.6757913780955855
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16263,84,1.17 [0.94-1.45],0.1578101837713952
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,11872,66,0.97 [0.73-1.29],0.8329198578156641
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),11919,113,1.02 [0.83-1.26],0.8269524826644731
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17501,205,0.96 [0.81-1.13],0.6080631894604583
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,17697,401,0.94 [0.83-1.06],0.3017062473986105
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19459,88,1.17 [0.94-1.44],0.1547026479755548
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17742,1631,0.97 [0.92-1.03],0.337417188268095
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16238,59,0.98 [0.73-1.33],0.9203539988792396
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),11931,125,0.91 [0.73-1.13],0.3983640140719708
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16766,655,1.01 [0.93-1.11],0.7936401974918443
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13619,1813,1.01 [0.96-1.06],0.7344037608765053
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,18841,105,1.01 [0.80-1.26],0.9542561196871792
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19469,58,0.80 [0.57-1.14],0.2187084355596459
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16245,66,0.83 [0.60-1.15],0.2687235820192594
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17291,1112,1.02 [0.95-1.09],0.5475805119779303
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16264,85,0.88 [0.67-1.16],0.3648892349600953
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13542,1736,1.02 [0.97-1.08],0.4332624992356959
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17399,103,1.07 [0.87-1.32],0.5358970304051287
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16206,27,1.24 [0.88-1.74],0.2124157522594562
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16273,162,0.90 [0.74-1.09],0.2709406407178956
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16735,556,0.94 [0.85-1.04],0.2628101865496764
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19154,418,1.03 [0.92-1.15],0.6586375916837918
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16655,544,0.97 [0.88-1.08],0.6125792856852141
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19346,447,0.96 [0.86-1.08],0.4931996024719933
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19457,57,1.09 [0.82-1.45],0.550498902659869
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16318,139,1.00 [0.83-1.22],0.9758647995989014
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15159,718,1.02 [0.94-1.11],0.6876933735848638
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16712,533,1.00 [0.91-1.11],0.9495876105253926
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16420,241,0.89 [0.75-1.04],0.137269786147013
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",11869,63,1.11 [0.85-1.45],0.4372913881458745
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14408,2602,1.01 [0.97-1.06],0.5316691987648082
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12503,697,1.05 [0.96-1.14],0.2923778665694813
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19048,312,0.99 [0.87-1.13],0.8681898180582568
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19430,59,0.85 [0.60-1.19],0.334118535036173
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17262,58,1.00 [0.73-1.36],0.9812128300484952
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,11865,59,0.82 [0.58-1.15],0.2435969956384202
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16200,89,1.07 [0.85-1.34],0.5670681188457236
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12265,459,0.97 [0.87-1.08],0.578927121374625
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16460,281,1.00 [0.88-1.15],0.942403461573821
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16348,237,0.95 [0.81-1.11],0.4851376021041708
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16322,211,0.95 [0.81-1.12],0.5512077517019673
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,13729,60,1.05 [0.79-1.40],0.7379034544343508
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19460,60,1.04 [0.78-1.39],0.7749577816710689
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16645,466,1.02 [0.92-1.13],0.7300054208574547
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],18820,84,1.16 [0.93-1.44],0.1760101740559927
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18378,2199,1.02 [0.98-1.07],0.3553912874118106
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16300,121,0.89 [0.71-1.12],0.3141791288912233
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16682,571,1.00 [0.91-1.11],0.9221111343251212
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18313,221,0.89 [0.76-1.06],0.1918405595128207
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16308,197,0.90 [0.76-1.08],0.2659603586697717
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17736,1625,0.98 [0.93-1.04],0.5926029535200855
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17170,1059,0.98 [0.92-1.06],0.6737946097638869
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16227,48,1.20 [0.92-1.59],0.184054019692455
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,18843,107,1.02 [0.82-1.27],0.8749402444692395
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16324,145,1.00 [0.83-1.21],0.9939572289828568
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16256,77,0.92 [0.70-1.21],0.5494055300892104
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),11865,59,0.95 [0.70-1.29],0.7355593606742202
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18368,1782,0.98 [0.93-1.04],0.4969895707785042
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7867,22,1.23 [0.82-1.84],0.3185003713399503
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,9980,27,1.10 [0.74-1.64],0.6255769931357549
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19205,260,1.02 [0.89-1.17],0.7658883274383006
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19035,90,1.06 [0.84-1.33],0.6250145559651636
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18294,1708,0.99 [0.94-1.05],0.827273655831168
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19296,85,0.99 [0.77-1.28],0.9488771321077718
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19258,325,1.01 [0.89-1.15],0.8625729992054659
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Cystitis,16346,245,1.01 [0.87-1.17],0.8882724890350618
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Dialysis,16653,67,0.94 [0.70-1.26],0.6596990830450616
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8514,1767,0.94 [0.89-0.99],0.0244612929431453
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10060,107,1.05 [0.85-1.30],0.6354562407569836
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Endometriosis,7878,33,1.10 [0.76-1.60],0.59934186695463
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8329,484,0.91 [0.82-1.02],0.1089498874601989
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16088,5172,0.95 [0.92-0.98],0.0021507898264564
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19278,67,1.01 [0.76-1.34],0.9430214673145068
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Hydrocele,6850,103,0.81 [0.63-1.05],0.1061616349426973
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,16618,273,0.93 [0.80-1.07],0.2993378682231933
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8243,1496,0.90 [0.84-0.96],0.0008019361746344
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10114,133,1.08 [0.90-1.31],0.3967931017625682
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6853,106,0.73 [0.56-0.96],0.0233679453291696
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16171,70,1.16 [0.92-1.47],0.2135900534601497
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8708,863,0.90 [0.83-0.98],0.0173436935897219
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,6799,52,0.82 [0.58-1.17],0.2847279775802185
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7877,32,0.85 [0.53-1.35],0.4860373687933912
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19470,73,1.15 [0.91-1.45],0.2487400057880185
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19466,67,1.13 [0.88-1.46],0.3353242035202903
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18477,2376,0.96 [0.91-1.00],0.0724879391593588
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,16886,785,0.96 [0.88-1.04],0.3420737350953894
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,9998,45,1.02 [0.73-1.43],0.911760789707068
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19418,485,1.04 [0.94-1.15],0.4469933984606011
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6869,122,1.01 [0.82-1.23],0.9380364499958752
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6879,132,1.05 [0.87-1.27],0.5887962038548356
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,6870,123,1.02 [0.84-1.24],0.8302990623528369
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19447,68,0.97 [0.73-1.29],0.8411913112543619
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,17950,1849,0.97 [0.91-1.02],0.2114515568223088
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10051,70,1.05 [0.80-1.37],0.7333911559188544
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,7909,64,0.95 [0.71-1.28],0.7525650074473704
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",7978,133,0.93 [0.75-1.14],0.4766831541452211
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,7891,46,0.91 [0.63-1.30],0.597521005446864
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,7930,85,1.01 [0.79-1.28],0.966339459121623
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16665,320,0.92 [0.80-1.05],0.230703744091668
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19091,158,1.00 [0.83-1.20],0.995217529418352
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,7950,105,0.97 [0.77-1.22],0.7987963191392308
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7866,21,0.89 [0.52-1.52],0.6647405098062231
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8026,181,0.90 [0.75-1.08],0.2640665594151871
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,7927,82,1.13 [0.90-1.41],0.2877441327205515
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8022,177,0.83 [0.69-1.01],0.0677454413155716
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19256,45,0.74 [0.49-1.12],0.1495206165529785
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6871,124,1.00 [0.82-1.22],0.99085132861647
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19279,2934,0.98 [0.94-1.02],0.3777661774133884
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16420,75,0.80 [0.59-1.09],0.1574769809090147
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16719,133,1.01 [0.83-1.23],0.9255034907717372
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,18978,33,0.84 [0.54-1.32],0.4514725227641575
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16326,225,0.93 [0.79-1.09],0.3811740394980193
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19282,337,1.01 [0.90-1.15],0.8385621424234806
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7879,34,0.89 [0.59-1.35],0.5829331476671289
